Empowering Confidence

through Innovation

Company Profile

Imeik Technology Development Co., Ltd., founded in 2004, is a High-Tech Enterprise dedicated to the R&D and transformation of biomedical materials and biopharmaceutical products.


Imeik has successfully industrialized a series of sodium hyaluronate-based dermal fillers, poly-L-lactic acid-based dermal fillers, and poly-dioxanone facial threads, while advancing the development of biopharmaceuticals such as recombinant proteins and polypeptides. Its current clinical applications and R&D pipeline span medical aesthetics, dermatology, general surgery, and metabolic disease treatment.


As China's earliest innovator in self-developed biomedical materials for medical aesthetics, Imeik has consistently prioritized innovation and upheld its mission of serving industrial development while creating healthier, more fulfilling lives. The Company has strategically shaped the medical aesthetics landscape across products, technologies, services, and ecosystem development. Now an internationally leading provider of innovative medical aesthetic solutions, Imeik continues to meet consumers' evolving needs for personalized and diversified care.

1200

+

Employees worldwode

25,000

+

Doctors engaged in our Network

3.03

Billion RMB

2024 Operating Revenue

1.96

Billion RMB

2024 Net Income

304

Million RMB

2024 R&D Expenses

8.34

Billion RMB

Total Assets

95

%

S&P Global CSA Percentile Rank

Business Ecosystem

In-House R&D

Mergers & Acquisitions

Global Scaling

Licensing

Joint Ventures

Corporate Culture

  • mission

    mission

    With technology, we cultivate beautiful look, beautiful mind and better life.

  • Vision

    Vision

    Creating a better and more dignified life.

  • Value

    Value

    Simplifying with strength; foreseeing with wisdom.

  • Development Strategy

    Development Strategy

    The medical aesthetics industry uniquely integrates medical rigor with consumer-driven agility. At Imeik, our strategic focus lies in harmonizing the meticulous "slow science" of medical R&D with the dynamic "fast evolution" of market demands. We actively pursue growth opportunities in the broader health industry while rapidly responding to emerging consumer needs. Concurrently, we maintain an uncompromising commitment to in-house innovation, embracing deliberate, craftsmanship-driven development to ensure clinically validated solutions and industry sustainability. This dual approach fuels our unwavering mission: to pioneer advancements that redefine ‘better aging’ and elevate life’s potential.